Detailed Mechanism Funding and Narrative

Years of mechanism: 2007 2008 2009

Details for Mechanism ID: 5175
Country/Region: Vietnam
Year: 2007
Main Partner: Partnership for Supply Chain Management
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $12,838,228

Funding for Treatment: ARV Drugs (HTXD): $11,134,000

This activity is linked to HTXS SCMS (9412). SCMS will support the PEPFAR Vietnam 5-Year strategy to provide 22,000 persons with ART. Funding is being reprogrammed from previously planned funding for ARV drugs in the setting of reduced drug costs.

The Supply Chain Management System (SCMS) will support the following 3 objectives described in the program narrative: 1) enhance the capacity of governmental, specifically the new MOH/VAAC drug management unit, international and local partners to systematically identify, prioritize and address pharmaceutical management issues to improve access to and use of quality ARVs supported by the national treatment guidelines; 2) strengthen the pharmaceutical management capacity of referral, provincial, district, and other facilities to ensure an uninterrupted supply of quality HIV/AIDS pharmaceutical and other commodities at ART service delivery sites; and 3) procure $11,000,000 worth of ARVs on behalf of all USG civilian and Department of Defense ART implementation sites to support the current 2,600 patients, 7,500 by September 2007 and 14,000 by September 2008. All pediatrics formulations will be procured in coordination with the Clinton Foundation who will be purchasing the majority of the supply for Vietnam.

Specifically SCMS will: 1) provide technical assistance (TA) to enhance decision-making at the VAAC, other central agencies, and donors for HIV/AIDS-related pharmaceutical and commodity management such as in-country forecasting and drug management and play a coordinating role with partners' organization on pharmaceutical issues; 2) provide TA to partners and sites to clarify the implications of changes in treatment guidelines, number of ART implementation sites, various funding scenarios, and changes in the market; manage procurement, importation, storage, distribution and supply of quality ARVs, consistent with USAID procurement guidelines, based on available funding, and develop a distribution plan for implementation sites; 3) closely collaborate and support the VAAC pharmacy unit to build capacity and move towards coordination of procurement and distribution of all ARVs; 4) strengthen drug management information systems to provide timely accurate information regarding procurement, distribution, and use of ARVs supplied by all partners; 5) develop and implement standard operating procedures (SOPs) at appropriate levels, train and supervise their effective implementation; 6) train pharmacy personnel on pharmaceutical management in HIV/AIDS, and related commodities; 7) develop and implement a monitoring and evaluation (M&E) plan in support of the national drug management M&E plan; and 8) disseminate information about ARV drug management to partner organizations and implementation sites, and share lessons learned with the broader community.

A significant cost savings has been achieved due to the availability of ARV fixed dose combination and the decrease in the price of sedond line ARV. This funding will be used to fund various activities in treatment, care and prevention detailed in the reprogramming templates.

Funding for Treatment: Adult Treatment (HTXS): $1,704,228

This activity is linked to HTXD SCMS (9381).

Funds allocated to the Supply Chain Management System (SCMS) will continue similar activities from FY05 and FY06 implemented by Management Sciences for Health and support the Vietnam PEPFAR 5-Year Strategy to: 1) enhance the capacity of governmental, international and local partners in Vietnam to systematically identify, prioritize and address pharmaceutical management issues to improve access to and use of quality pharmaceutical products and other commodities for care, prevention and treatment of HIV/AIDS; and 2) strengthen the pharmaceutical management capacity of referral, provincial, district, and other facilities to ensure an uninterrupted supply of quality HIV/AIDS pharmaceutical and other commodities at ART service delivery sites.

SCMS will support pharmaceutical site readiness at new PEPFAR-supported sites through training of 100 pharmacy staff, site monitoring, and ongoing quality assurance (QA) and supportive supervision. SCMS will develop standard operating procedures (SOPs) for pharmacies at all sites, with adaptations for national-level academic institutions. SCMS will also support MOH/VAAC capacity development and sustainability of activities through TA for forecasting, procurement and distribution as well as for pharmaceutical site readiness, implementation of SOPs, training and QA.

A total of $635,000 of these funds will support procurement, management and distribution of CD4 reagents for FACS Count machines for non-military ART implementation sites, in accordance with Vietnamese National Standard Treatment Guidelines and USAID procurement regulations. DOD will procure CD4 reagents for Military sites through a separate mechanism.